SEC Form 4 · accession 0001225208-18-008942
Merck & Co., Inc. · MRK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jennifer Zachary
Officer — EVP, General Counsel
Period of report
May 4, 2018
Accepted (ET)
May 8, 2018 · 5:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000310158
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F2 | — | May 4, 2018 | A | 17,316 | A | May 4, 2019 | May 4, 2021 | Common Stock | 17,316 | 17,316 | D |
| Stock Option (right to buy)F3 | $57.75 | May 4, 2018 | A | 73,191 | A | May 4, 2019 | May 3, 2028 | Common Stock | 73,191 | 73,191 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- F2These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.
- F3The option vests and becomes exercisable in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.